Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yujiro Uchida is active.

Publication


Featured researches published by Yujiro Uchida.


Journal of Infection and Chemotherapy | 2008

An outbreak of Pseudomonas aeruginosa infections following thoracic surgeries occurring via the contamination of bronchoscopes and an automatic endoscope reprocessor

Nobuyuki Shimono; Takahiro Takuma; Noriko Tsuchimochi; Akira Shiose; Masayuki Murata; Yoko Kanamoto; Yujiro Uchida; Shigeki Morita; Hiroko Matsumoto; Jun Hayashi

An outbreak of Pseudomonas aeruginosa infections occurred after thoracic surgeries performed between May and June 2003. Clinical data of seven patients were reviewed and the fact was revealed that bronchoscopes were used during endotracheal intubation for one-lung ventilation in most patients. P. aeruginosa was recovered from the sputum of these patients at a very early stage post-operation. Environmental samples from bronchoscopes and an automated endoscope reprocessor (AER) were cultured and P. aeruginosa strains were recovered from all of them. All of these strains were confirmed to be identical by pulsed-field gel electrophoresis (PFGE). Inspection of the sterilization cycles of bronchoscopes revealed inappropriate management of bronchoscopes and a flaw in the AER; once its detergent tank was contaminated, it was not possible to disinfect it. After all the bronchoscopes had been disinfected, and the washing machine had been remodeled, with the washing process confirmed to be appropriate, the outbreak finally ended. This outbreak had two causes, a flaw in the AER and inappropriate disinfection procedures. Outbreaks associated with bronchoscopic examinations have been reported elsewhere. Bronchoscopes are widely used to facilitate endotracheal intubation, especially for one-lung anesthesia. Although they are used for only a short time during anesthetic procedures, we should handle them more carefully.


International Journal of Antimicrobial Agents | 2010

Clonal spread in Eastern Asia of ciprofloxacin-resistant Escherichia coli serogroup O25 strains, and associated virulence factors

Yujiro Uchida; Tomomi Mochimaru; Yuiko Morokuma; Makiko Kiyosuke; Masako Fujise; Fujiko Eto; Yoshihiro Eriguchi; Yoji Nagasaki; Nobuyuki Shimono; Dongchon Kang

A significant problem in the field of infectious diseases is the increase in fluoroquinolone (FQ)-resistant Escherichia coli. Although mutation of strains and clonal dissemination are supposed to be the cause of this increase, little is known about the prevalence of this organism. We investigated 219 FQ-resistant E. coli strains in Japan and nine Asian countries by serotyping and genotyping. Seventy-one strains (32.4%) were serogroup O25, which was prevalent in South Korea, China and Japan, especially in the southwest part of Japan. Aerobactin, a virulence factor in uropathogenic and avian pathogenic E. coli, was associated with the presence of FQ-resistant O25 strains of E. coli. Seven of the seventy-one FQ-resistant E. coli O25 had extended-spectrum beta-lactamase genes (six CTX-M-14 and one SHV-12), however, we were unable to find any E. coli O25-ST131 clone that produced CTX-M-15, which was previously reported to have emerged across continents. These data demonstrate that a clonal group of FQ-resistant and virulent E. coli recently became prevalent at least in East Asia and suggest that this might become a public health problem because the strains may acquire resistance to other antimicrobial agents.


International Journal of Antimicrobial Agents | 2010

Geographic distribution of fluoroquinolone-resistant Escherichia coli strains in Asia.

Yujiro Uchida; Tomomi Mochimaru; Yuiko Morokuma; Makiko Kiyosuke; Masako Fujise; Fujiko Eto; Yukiko Harada; Masako Kadowaki; Nobuyuki Shimono; Dongchon Kang

Fluoroquinolone (FQ) resistance is usually caused by point mutations within the quinolone resistance-determining regions (QRDRs) of gyrA, gyrB, parC and/or parE. However, little is known about the worldwide increase in FQ-resistant Escherichia coli or, more specifically, about the geographical distribution of QRDR mutations and the clonal spread of isolates. In this study, we analysed 68 FQ-resistant E. coli isolates from eight Asian countries using QRDR amino acid mutation patterns and examined their susceptibility to FQs. Of the isolates, 38% had mutations at S83 and D87 of GyrA and S80 of ParC (MM/-/M-/-) and 34% had mutations at S83 and D87 of GyrA, S80 of ParC and S458 of ParE (MM/-/M-/M). MIC(50) values (minimum inhibitory concentrations for 50% of the isolates) for isolates with at least mutation at S458 of ParE for ciprofloxacin and prulifloxacin were relatively higher than MIC(50) values of isolates without this mutation. Based on their geographic distribution and the QRDR mutation patterns, the isolates were divided into a common type in which the organisms were isolated from three or more countries, and a local type in which the isolates were from one or two countries. Mutation types at S83L and D87N in GyrA and S80I in ParC with no or another site in the QRDR were the most frequent among the FQ-resistant isolates, especially among the common type. Gene typing indicated that isolates in the common type were not similar between countries. These data suggest that the increase in FQ-resistant E. coli strains is mainly generated by mutations in the QRDR in each geographical area rather than through intercontinental spread.


Journal of Antimicrobial Chemotherapy | 2009

Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model

Yoji Nagasaki; Yoshihiro Eriguchi; Yujiro Uchida; Noriko Miyake; Yoriko Maehara; Masako Kadowaki; Mine Harada; Koichi Akashi; Nobuyuki Shimono

OBJECTIVES Antifungal monotherapy with polyenes, azoles or echinocandins is not always effective for invasive pulmonary aspergillosis (IPA). The main purpose of this study was to evaluate the efficacy of a combination of micafungin and amphotericin B for the primary treatment of IPA in an immunocompromised mouse model. METHODS Female ICR mice were used in all experiments. An immunosuppressive state was induced in mice by an intraperitoneal injection of cyclophosphamide. Mice were intratracheally inoculated with Aspergillus fumigatus conidia, treated with micafungin, amphotericin B or both for 7 days, and were tested for their survival 20 days after the Aspergillus inoculation. Fungal burden in lungs, serum galactomannan index (GMI) and histopathology of lungs, spleen and kidneys were also evaluated. RESULTS Combination therapy with micafungin and amphotericin B gave excellent survival of infected mice compared with monotherapy with micafungin or amphotericin B alone. Combined therapy reduced the fungal burden in the lungs and the serum GM levels compared with monotherapy or untreated controls, resulting in a significant histological improvement with disappearance of fungi in the lungs. CONCLUSIONS These findings suggest that combination therapy with micafungin and amphotericin B is more effective compared with monotherapy with either of them alone for IPA treatment.


Journal of Infection and Chemotherapy | 2008

Antimicrobial susceptibility and molecular epidemiological analysis of clinical strains of Pseudomonas aeruginosa

Noriko Tsuchimochi; Takahiro Takuma; Nobuyuki Shimono; Yoji Nagasaki; Yujiro Uchida; Mine Harada

Three hundred and seventy-one strains of Pseudomonas aeruginosa were isolated at the laboratory of Kyushu University Hospital in Japan from May 2002 through January 2003. Large proportions of isolated strains were resistant to carbapenems: 37.5% to imipenem, 21.3% to biapenem, and 18.3% to meropenem. A survey of injectable antibacterial agents used in our hospital during the corresponding period showed that carbapenems were most frequently used. Multidrug-resistant P. aeruginosa (MDRP) strains and metallo-β-lactamase producing strains were isolated at frequencies of 1.6% (6 strains) and 0.81% (3 strains), respectively. By molecular epidemiological analysis, neither MDRP nor metallo-β-lactamase producing strains were molecularly related, whereas some imipenem-resistant strains appeared to be epidemic strains, suggesting a possibility that they might spread by nosocomial infection. To control nosocomial infection, it is important to know a trend in drug-resistant P. aeruginosa and to prevent the spread of not only MDRP and metallo-β-lactamase producing strains but also imipenem-resistant P. aeruginosa strains.


Journal of Infection and Chemotherapy | 2012

Vigorous cleaning and adequate ventilation are necessary to control an outbreak in a neonatal intensive care unit

Nobuyuki Shimono; Jun Hayashi; Hiroko Matsumoto; Noriko Miyake; Yujiro Uchida; Shinji Shimoda; Norihiro Furusyo; Koichi Akashi

An outbreak of Bacillus cereus (B. cereus) bacteremia occurred in our neonatal intensive care unit (NICU) in July 2005. Many strains of B. cereus were cultured from patient specimens, as well as from environmental samples such as the surfaces of instruments and air in the NICU. Some of these strains were analyzed by pulsed field gel electrophoresis, and several were confirmed to be identical. We speculated that the bacterial load in the environment had initially increased and then possibly spread throughout the NICU facility via the airflow of the ventilation system. For this reason, besides maintaining standard precautions, we performed a vigorous clean of the NICU, and covered the vents to prevent dust falling from them. These protective measures ended the outbreak. In the hospital environment, adequate ventilation is important, especially in single-occupancy isolation rooms and operating theaters. However, the criteria for the adequate ventilation of multioccupancy rooms for acute care environments such as the NICU have not yet been defined. We need to pay more attention to these environmental factors in order to avoid cross contamination and infectious outbreaks.


Internal Medicine | 2008

Successful treatment of pituitary abscess with oral administration of sparfloxacin

Yujiro Uchida; Noriko Tsuchimochi; Miwako Oku; Naoko Fujihara; Nobuyuki Shimono; Kaoru Okada; Mine Harada


Clinica Chimica Acta | 2009

High-dose penicillin G-treatment causes underestimation of serum albumin measured by a modified BCP method

Miyuki Ono; Yoshimasa Aoki; Michiko Masumoto; Taeko Hotta; Yujiro Uchida; Yuzo Kayamori; Dongchon Kang


The Journal of the Japanese Association for Infectious Diseases | 2010

Hematological unit invasive aspergillosis epidemiology

Yoriko Maehara; Yoji Nagasaki; Masako Kadowaki; Yoshihiro Eriguchi; Noriko Miyake; Yujiro Uchida; Koji Nagafuji; Nobuyuki Shimono


The Journal of Antibiotics | 2011

Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus on in vitro

Noriko Miyake; Masako Kadowaki; Yoriko Sato; Yoshihiro Eriguchi; Yoji Nagasaki; Yukiko Harada; Yujiro Uchida; Nobuyuki Shimono

Collaboration


Dive into the Yujiro Uchida's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge